Medrobotics ® announces the first sale in Europe of the Flex ® robotic system for applications in the gastroenterological field

Friday, October 05, 2018

Medrobotics Corp. today announced the first European sale of the Flex ® robotic system for gastroenterology applications. The University of Health and Science Hospital of Turin will be the first European facility to offer Scarfree ™ endoscopic interventional procedures . Patients and medical staff can take advantage of the advantages offered by the system, such as the clarity of the 3D display, the robotic precision, the stability of the platform and the potential reduction in the duration of the interventions.

"In Europe, colorectal carcinoma is the second leading cause of cancer mortality," said Samuel Straface, Ph.D., president and CEO of Medrobotics. "Patients with cancer and non-malignant lesions are treated by gastroenterologists and surgeons colorectal, robotic Flex ® it offers clinicians the ability to make the simplest treatments and less invasive than is the case with conventional flexible endoscopes."

Medrobotics commercializes the Flex ® robotic system , the first and only robotic surgical platform that allows access through Scarfree ™ procedures to anatomical areas difficult to reach during the ENT, colorectal and gastroenterological procedures. The Flex ® robotic system has received numerous awards, including the 'Best-in-Show' award at the 2016 Medical Design Excellence Awards (MDEA) and the 'Best New Product' at the 2017 Edison Awards. Within the hospital facilities, the portability and simplicity of use of the Flex ® robotic system they offer potential access for a greater number of patients to minimally invasive surgical options in operating rooms and endoscopy units, unlike other surgical systems.

About Medrobotics
Medrobotics Corporation ( www.Medrobotics.com ) is a private company operating in the medical device industry. Headquartered in Raynham, Massachusetts, it manufactures and markets the Flex ® robotic system , the first ever orientable and moldable surgical robot platform. The Flex ® robotic system offers surgeons the unique ability to navigate complex anatomical areas through a single entry point of reduced size, to operate in areas of the body that are difficult to reach and otherwise inaccessible with straight and rigid surgical instruments. The company's vision is to offer Scarfree ™ procedure optionsto a higher number of patients. Medrobotics has received from the FDA the authorization for the marketing of the Flex ® robotic system for ENT applications in July 2015 and for the color correction procedures in May 2017. The authorization for the CE mark was granted in March 2014 .

The original text of this announcement, written in the source language, is the official version that is authentic. Translations are offered solely for the convenience of the reader and must refer to the original text, which is the only legally valid one.

Contacts
Media:
For Medrobotics Corporation
Kevin Knight
(214) 732-9392
kknightpr@gmail.com